Crossmark

Hepatitis B virus reactivation liver injury during anti-tuberculosis treatment in HBeAg-negative hepatitis B virus/tuberculosis co-infected patients with low baseline hepatitis B virus DNA

Crossref DOI link: https://doi.org/10.1186/s40001-026-04598-0

Published Online: 2026-05-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gu, Bin

Tang, Min

Zhou, Yulan

Wu, Chenxi

Lu, Hengjian

Gong, Guozhong
License Information

Text and Data Mining valid from 2026-05-15

Accepted Manuscript valid from 2026-05-15
More Information

Article History

Received: 5 December 2025

Accepted: 8 May 2026

First Online: 15 May 2026

Declarations

:

: This study was approved by the Ethics Committee of The Second People’s Hospital of Chenzhou (approval number: 2023–1). All methods were carried out in accordance with Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below